Global Eye Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Eye Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Eye Injection industry chain, the market status of Age-related Macular Degeneration (AMD) (Ranibizumab, Bevacizumab), Diabetic Retinopathy (Ranibizumab, Bevacizumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Eye Injection.
Regionally, the report analyzes the Eye Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Eye Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Eye Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Eye Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ranibizumab, Bevacizumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Eye Injection market.
Regional Analysis: The report involves examining the Eye Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Eye Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Eye Injection:
Company Analysis: Report covers individual Eye Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Eye Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age-related Macular Degeneration (AMD), Diabetic Retinopathy).
Technology Analysis: Report covers specific technologies relevant to Eye Injection. It assesses the current state, advancements, and potential future developments in Eye Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Eye Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Eye Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Eye Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Eye Injection, with price, sales, revenue and global market share of Eye Injection from 2019 to 2024.
Chapter 3, the Eye Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eye Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Eye Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Eye Injection.
Chapter 14 and 15, to describe Eye Injection sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the Eye Injection industry chain, the market status of Age-related Macular Degeneration (AMD) (Ranibizumab, Bevacizumab), Diabetic Retinopathy (Ranibizumab, Bevacizumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Eye Injection.
Regionally, the report analyzes the Eye Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Eye Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Eye Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Eye Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ranibizumab, Bevacizumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Eye Injection market.
Regional Analysis: The report involves examining the Eye Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Eye Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Eye Injection:
Company Analysis: Report covers individual Eye Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Eye Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age-related Macular Degeneration (AMD), Diabetic Retinopathy).
Technology Analysis: Report covers specific technologies relevant to Eye Injection. It assesses the current state, advancements, and potential future developments in Eye Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Eye Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Eye Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Ranibizumab
- Bevacizumab
- Aflibercept
- Brolucizumab
- Faricimab
- Others
- Age-related Macular Degeneration (AMD)
- Diabetic Retinopathy
- Retinal Vein Occlusion (RVO)
- Retinopathy of Prematurity (ROP)
- Uveitis
- Neovascular Glaucoma
- Others
- Sanofi
- Novartis
- Bayer
- Genentech
- Apellis Pharmaceuticals, Inc.
- Coherus BioSciences Inc.
- Iveric Bio
- Regeneron
- Roche
- Fagron
- Qilu Pharmaceutical Co.,Ltd.
- Chengdu Kanghong Pharmaceutical Group
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Eye Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Eye Injection, with price, sales, revenue and global market share of Eye Injection from 2019 to 2024.
Chapter 3, the Eye Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eye Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Eye Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Eye Injection.
Chapter 14 and 15, to describe Eye Injection sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Eye Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Eye Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Ranibizumab
1.3.3 Bevacizumab
1.3.4 Aflibercept
1.3.5 Brolucizumab
1.3.6 Faricimab
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Eye Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Age-related Macular Degeneration (AMD)
1.4.3 Diabetic Retinopathy
1.4.4 Retinal Vein Occlusion (RVO)
1.4.5 Retinopathy of Prematurity (ROP)
1.4.6 Uveitis
1.4.7 Neovascular Glaucoma
1.4.8 Others
1.5 Global Eye Injection Market Size & Forecast
1.5.1 Global Eye Injection Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Eye Injection Sales Quantity (2019-2030)
1.5.3 Global Eye Injection Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Eye Injection Product and Services
2.1.4 Sanofi Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Eye Injection Product and Services
2.2.4 Novartis Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Eye Injection Product and Services
2.3.4 Bayer Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 Genentech
2.4.1 Genentech Details
2.4.2 Genentech Major Business
2.4.3 Genentech Eye Injection Product and Services
2.4.4 Genentech Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Genentech Recent Developments/Updates
2.5 Apellis Pharmaceuticals, Inc.
2.5.1 Apellis Pharmaceuticals, Inc. Details
2.5.2 Apellis Pharmaceuticals, Inc. Major Business
2.5.3 Apellis Pharmaceuticals, Inc. Eye Injection Product and Services
2.5.4 Apellis Pharmaceuticals, Inc. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
2.6 Coherus BioSciences Inc.
2.6.1 Coherus BioSciences Inc. Details
2.6.2 Coherus BioSciences Inc. Major Business
2.6.3 Coherus BioSciences Inc. Eye Injection Product and Services
2.6.4 Coherus BioSciences Inc. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Coherus BioSciences Inc. Recent Developments/Updates
2.7 Iveric Bio
2.7.1 Iveric Bio
Details
2.7.2 Iveric Bio
Major Business
2.7.3 Iveric Bio
Eye Injection Product and Services
2.7.4 Iveric Bio
Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Iveric Bio
Recent Developments/Updates
2.8 Regeneron
2.8.1 Regeneron Details
2.8.2 Regeneron Major Business
2.8.3 Regeneron Eye Injection Product and Services
2.8.4 Regeneron Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Regeneron Recent Developments/Updates
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business
2.9.3 Roche Eye Injection Product and Services
2.9.4 Roche Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Roche Recent Developments/Updates
2.10 Fagron
2.10.1 Fagron Details
2.10.2 Fagron Major Business
2.10.3 Fagron Eye Injection Product and Services
2.10.4 Fagron Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Fagron Recent Developments/Updates
2.11 Qilu Pharmaceutical Co.,Ltd.
2.11.1 Qilu Pharmaceutical Co.,Ltd. Details
2.11.2 Qilu Pharmaceutical Co.,Ltd. Major Business
2.11.3 Qilu Pharmaceutical Co.,Ltd. Eye Injection Product and Services
2.11.4 Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.12 Chengdu Kanghong Pharmaceutical Group
2.12.1 Chengdu Kanghong Pharmaceutical Group Details
2.12.2 Chengdu Kanghong Pharmaceutical Group Major Business
2.12.3 Chengdu Kanghong Pharmaceutical Group Eye Injection Product and Services
2.12.4 Chengdu Kanghong Pharmaceutical Group Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: EYE INJECTION BY MANUFACTURER
3.1 Global Eye Injection Sales Quantity by Manufacturer (2019-2024)
3.2 Global Eye Injection Revenue by Manufacturer (2019-2024)
3.3 Global Eye Injection Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Eye Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Eye Injection Manufacturer Market Share in 2023
3.4.2 Top 6 Eye Injection Manufacturer Market Share in 2023
3.5 Eye Injection Market: Overall Company Footprint Analysis
3.5.1 Eye Injection Market: Region Footprint
3.5.2 Eye Injection Market: Company Product Type Footprint
3.5.3 Eye Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Eye Injection Market Size by Region
4.1.1 Global Eye Injection Sales Quantity by Region (2019-2030)
4.1.2 Global Eye Injection Consumption Value by Region (2019-2030)
4.1.3 Global Eye Injection Average Price by Region (2019-2030)
4.2 North America Eye Injection Consumption Value (2019-2030)
4.3 Europe Eye Injection Consumption Value (2019-2030)
4.4 Asia-Pacific Eye Injection Consumption Value (2019-2030)
4.5 South America Eye Injection Consumption Value (2019-2030)
4.6 Middle East and Africa Eye Injection Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Eye Injection Sales Quantity by Type (2019-2030)
5.2 Global Eye Injection Consumption Value by Type (2019-2030)
5.3 Global Eye Injection Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Eye Injection Sales Quantity by Application (2019-2030)
6.2 Global Eye Injection Consumption Value by Application (2019-2030)
6.3 Global Eye Injection Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Eye Injection Sales Quantity by Type (2019-2030)
7.2 North America Eye Injection Sales Quantity by Application (2019-2030)
7.3 North America Eye Injection Market Size by Country
7.3.1 North America Eye Injection Sales Quantity by Country (2019-2030)
7.3.2 North America Eye Injection Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Eye Injection Sales Quantity by Type (2019-2030)
8.2 Europe Eye Injection Sales Quantity by Application (2019-2030)
8.3 Europe Eye Injection Market Size by Country
8.3.1 Europe Eye Injection Sales Quantity by Country (2019-2030)
8.3.2 Europe Eye Injection Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Eye Injection Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Eye Injection Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Eye Injection Market Size by Region
9.3.1 Asia-Pacific Eye Injection Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Eye Injection Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Eye Injection Sales Quantity by Type (2019-2030)
10.2 South America Eye Injection Sales Quantity by Application (2019-2030)
10.3 South America Eye Injection Market Size by Country
10.3.1 South America Eye Injection Sales Quantity by Country (2019-2030)
10.3.2 South America Eye Injection Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Eye Injection Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Eye Injection Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Eye Injection Market Size by Country
11.3.1 Middle East & Africa Eye Injection Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Eye Injection Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Eye Injection Market Drivers
12.2 Eye Injection Market Restraints
12.3 Eye Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Eye Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Eye Injection
13.3 Eye Injection Production Process
13.4 Eye Injection Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Eye Injection Typical Distributors
14.3 Eye Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Eye Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Eye Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Ranibizumab
1.3.3 Bevacizumab
1.3.4 Aflibercept
1.3.5 Brolucizumab
1.3.6 Faricimab
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Eye Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Age-related Macular Degeneration (AMD)
1.4.3 Diabetic Retinopathy
1.4.4 Retinal Vein Occlusion (RVO)
1.4.5 Retinopathy of Prematurity (ROP)
1.4.6 Uveitis
1.4.7 Neovascular Glaucoma
1.4.8 Others
1.5 Global Eye Injection Market Size & Forecast
1.5.1 Global Eye Injection Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Eye Injection Sales Quantity (2019-2030)
1.5.3 Global Eye Injection Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Eye Injection Product and Services
2.1.4 Sanofi Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Eye Injection Product and Services
2.2.4 Novartis Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Eye Injection Product and Services
2.3.4 Bayer Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 Genentech
2.4.1 Genentech Details
2.4.2 Genentech Major Business
2.4.3 Genentech Eye Injection Product and Services
2.4.4 Genentech Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Genentech Recent Developments/Updates
2.5 Apellis Pharmaceuticals, Inc.
2.5.1 Apellis Pharmaceuticals, Inc. Details
2.5.2 Apellis Pharmaceuticals, Inc. Major Business
2.5.3 Apellis Pharmaceuticals, Inc. Eye Injection Product and Services
2.5.4 Apellis Pharmaceuticals, Inc. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
2.6 Coherus BioSciences Inc.
2.6.1 Coherus BioSciences Inc. Details
2.6.2 Coherus BioSciences Inc. Major Business
2.6.3 Coherus BioSciences Inc. Eye Injection Product and Services
2.6.4 Coherus BioSciences Inc. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Coherus BioSciences Inc. Recent Developments/Updates
2.7 Iveric Bio
2.7.1 Iveric Bio
Details
2.7.2 Iveric Bio
Major Business
2.7.3 Iveric Bio
Eye Injection Product and Services
2.7.4 Iveric Bio
Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Iveric Bio
Recent Developments/Updates
2.8 Regeneron
2.8.1 Regeneron Details
2.8.2 Regeneron Major Business
2.8.3 Regeneron Eye Injection Product and Services
2.8.4 Regeneron Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Regeneron Recent Developments/Updates
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business
2.9.3 Roche Eye Injection Product and Services
2.9.4 Roche Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Roche Recent Developments/Updates
2.10 Fagron
2.10.1 Fagron Details
2.10.2 Fagron Major Business
2.10.3 Fagron Eye Injection Product and Services
2.10.4 Fagron Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Fagron Recent Developments/Updates
2.11 Qilu Pharmaceutical Co.,Ltd.
2.11.1 Qilu Pharmaceutical Co.,Ltd. Details
2.11.2 Qilu Pharmaceutical Co.,Ltd. Major Business
2.11.3 Qilu Pharmaceutical Co.,Ltd. Eye Injection Product and Services
2.11.4 Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.12 Chengdu Kanghong Pharmaceutical Group
2.12.1 Chengdu Kanghong Pharmaceutical Group Details
2.12.2 Chengdu Kanghong Pharmaceutical Group Major Business
2.12.3 Chengdu Kanghong Pharmaceutical Group Eye Injection Product and Services
2.12.4 Chengdu Kanghong Pharmaceutical Group Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: EYE INJECTION BY MANUFACTURER
3.1 Global Eye Injection Sales Quantity by Manufacturer (2019-2024)
3.2 Global Eye Injection Revenue by Manufacturer (2019-2024)
3.3 Global Eye Injection Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Eye Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Eye Injection Manufacturer Market Share in 2023
3.4.2 Top 6 Eye Injection Manufacturer Market Share in 2023
3.5 Eye Injection Market: Overall Company Footprint Analysis
3.5.1 Eye Injection Market: Region Footprint
3.5.2 Eye Injection Market: Company Product Type Footprint
3.5.3 Eye Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Eye Injection Market Size by Region
4.1.1 Global Eye Injection Sales Quantity by Region (2019-2030)
4.1.2 Global Eye Injection Consumption Value by Region (2019-2030)
4.1.3 Global Eye Injection Average Price by Region (2019-2030)
4.2 North America Eye Injection Consumption Value (2019-2030)
4.3 Europe Eye Injection Consumption Value (2019-2030)
4.4 Asia-Pacific Eye Injection Consumption Value (2019-2030)
4.5 South America Eye Injection Consumption Value (2019-2030)
4.6 Middle East and Africa Eye Injection Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Eye Injection Sales Quantity by Type (2019-2030)
5.2 Global Eye Injection Consumption Value by Type (2019-2030)
5.3 Global Eye Injection Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Eye Injection Sales Quantity by Application (2019-2030)
6.2 Global Eye Injection Consumption Value by Application (2019-2030)
6.3 Global Eye Injection Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Eye Injection Sales Quantity by Type (2019-2030)
7.2 North America Eye Injection Sales Quantity by Application (2019-2030)
7.3 North America Eye Injection Market Size by Country
7.3.1 North America Eye Injection Sales Quantity by Country (2019-2030)
7.3.2 North America Eye Injection Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Eye Injection Sales Quantity by Type (2019-2030)
8.2 Europe Eye Injection Sales Quantity by Application (2019-2030)
8.3 Europe Eye Injection Market Size by Country
8.3.1 Europe Eye Injection Sales Quantity by Country (2019-2030)
8.3.2 Europe Eye Injection Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Eye Injection Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Eye Injection Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Eye Injection Market Size by Region
9.3.1 Asia-Pacific Eye Injection Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Eye Injection Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Eye Injection Sales Quantity by Type (2019-2030)
10.2 South America Eye Injection Sales Quantity by Application (2019-2030)
10.3 South America Eye Injection Market Size by Country
10.3.1 South America Eye Injection Sales Quantity by Country (2019-2030)
10.3.2 South America Eye Injection Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Eye Injection Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Eye Injection Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Eye Injection Market Size by Country
11.3.1 Middle East & Africa Eye Injection Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Eye Injection Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Eye Injection Market Drivers
12.2 Eye Injection Market Restraints
12.3 Eye Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Eye Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Eye Injection
13.3 Eye Injection Production Process
13.4 Eye Injection Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Eye Injection Typical Distributors
14.3 Eye Injection Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Eye Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Eye Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Eye Injection Product and Services
Table 6. Sanofi Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Eye Injection Product and Services
Table 11. Novartis Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Eye Injection Product and Services
Table 16. Bayer Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. Genentech Basic Information, Manufacturing Base and Competitors
Table 19. Genentech Major Business
Table 20. Genentech Eye Injection Product and Services
Table 21. Genentech Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Genentech Recent Developments/Updates
Table 23. Apellis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Apellis Pharmaceuticals, Inc. Major Business
Table 25. Apellis Pharmaceuticals, Inc. Eye Injection Product and Services
Table 26. Apellis Pharmaceuticals, Inc. Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 28. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Coherus BioSciences Inc. Major Business
Table 30. Coherus BioSciences Inc. Eye Injection Product and Services
Table 31. Coherus BioSciences Inc. Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Coherus BioSciences Inc. Recent Developments/Updates
Table 33. Iveric Bio
Basic Information, Manufacturing Base and Competitors
Table 34. Iveric Bio
Major Business
Table 35. Iveric Bio
Eye Injection Product and Services
Table 36. Iveric Bio
Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Iveric Bio
Recent Developments/Updates
Table 38. Regeneron Basic Information, Manufacturing Base and Competitors
Table 39. Regeneron Major Business
Table 40. Regeneron Eye Injection Product and Services
Table 41. Regeneron Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Regeneron Recent Developments/Updates
Table 43. Roche Basic Information, Manufacturing Base and Competitors
Table 44. Roche Major Business
Table 45. Roche Eye Injection Product and Services
Table 46. Roche Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Roche Recent Developments/Updates
Table 48. Fagron Basic Information, Manufacturing Base and Competitors
Table 49. Fagron Major Business
Table 50. Fagron Eye Injection Product and Services
Table 51. Fagron Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Fagron Recent Developments/Updates
Table 53. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 55. Qilu Pharmaceutical Co.,Ltd. Eye Injection Product and Services
Table 56. Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 58. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 59. Chengdu Kanghong Pharmaceutical Group Major Business
Table 60. Chengdu Kanghong Pharmaceutical Group Eye Injection Product and Services
Table 61. Chengdu Kanghong Pharmaceutical Group Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 63. Global Eye Injection Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 64. Global Eye Injection Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Eye Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 66. Market Position of Manufacturers in Eye Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Eye Injection Production Site of Key Manufacturer
Table 68. Eye Injection Market: Company Product Type Footprint
Table 69. Eye Injection Market: Company Product Application Footprint
Table 70. Eye Injection New Market Entrants and Barriers to Market Entry
Table 71. Eye Injection Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Eye Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 73. Global Eye Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 74. Global Eye Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Eye Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Eye Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 77. Global Eye Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 78. Global Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 79. Global Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 80. Global Eye Injection Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Eye Injection Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Eye Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 83. Global Eye Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 84. Global Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 85. Global Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 86. Global Eye Injection Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Eye Injection Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Eye Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 89. Global Eye Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 90. North America Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 91. North America Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 92. North America Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 93. North America Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 94. North America Eye Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 95. North America Eye Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 96. North America Eye Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Eye Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 99. Europe Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 100. Europe Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 101. Europe Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 102. Europe Eye Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 103. Europe Eye Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 104. Europe Eye Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Eye Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 107. Asia-Pacific Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 108. Asia-Pacific Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 109. Asia-Pacific Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 110. Asia-Pacific Eye Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 111. Asia-Pacific Eye Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 112. Asia-Pacific Eye Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Eye Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 115. South America Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 116. South America Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 117. South America Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 118. South America Eye Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 119. South America Eye Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 120. South America Eye Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Eye Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 123. Middle East & Africa Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 124. Middle East & Africa Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 125. Middle East & Africa Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 126. Middle East & Africa Eye Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 127. Middle East & Africa Eye Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 128. Middle East & Africa Eye Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Eye Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Eye Injection Raw Material
Table 131. Key Manufacturers of Eye Injection Raw Materials
Table 132. Eye Injection Typical Distributors
Table 133. Eye Injection Typical Customers
LIST OF FIGURE
s
Figure 1. Eye Injection Picture
Figure 2. Global Eye Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Eye Injection Consumption Value Market Share by Type in 2023
Figure 4. Ranibizumab Examples
Figure 5. Bevacizumab Examples
Figure 6. Aflibercept Examples
Figure 7. Brolucizumab Examples
Figure 8. Faricimab Examples
Figure 9. Others Examples
Figure 10. Global Eye Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Eye Injection Consumption Value Market Share by Application in 2023
Figure 12. Age-related Macular Degeneration (AMD) Examples
Figure 13. Diabetic Retinopathy Examples
Figure 14. Retinal Vein Occlusion (RVO) Examples
Figure 15. Retinopathy of Prematurity (ROP) Examples
Figure 16. Uveitis Examples
Figure 17. Neovascular Glaucoma Examples
Figure 18. Others Examples
Figure 19. Global Eye Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 20. Global Eye Injection Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 21. Global Eye Injection Sales Quantity (2019-2030) & (K Units)
Figure 22. Global Eye Injection Average Price (2019-2030) & (US$/Unit)
Figure 23. Global Eye Injection Sales Quantity Market Share by Manufacturer in 2023
Figure 24. Global Eye Injection Consumption Value Market Share by Manufacturer in 2023
Figure 25. Producer Shipments of Eye Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 26. Top 3 Eye Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 27. Top 6 Eye Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 28. Global Eye Injection Sales Quantity Market Share by Region (2019-2030)
Figure 29. Global Eye Injection Consumption Value Market Share by Region (2019-2030)
Figure 30. North America Eye Injection Consumption Value (2019-2030) & (USD Million)
Figure 31. Europe Eye Injection Consumption Value (2019-2030) & (USD Million)
Figure 32. Asia-Pacific Eye Injection Consumption Value (2019-2030) & (USD Million)
Figure 33. South America Eye Injection Consumption Value (2019-2030) & (USD Million)
Figure 34. Middle East & Africa Eye Injection Consumption Value (2019-2030) & (USD Million)
Figure 35. Global Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 36. Global Eye Injection Consumption Value Market Share by Type (2019-2030)
Figure 37. Global Eye Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 38. Global Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 39. Global Eye Injection Consumption Value Market Share by Application (2019-2030)
Figure 40. Global Eye Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 41. North America Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 42. North America Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 43. North America Eye Injection Sales Quantity Market Share by Country (2019-2030)
Figure 44. North America Eye Injection Consumption Value Market Share by Country (2019-2030)
Figure 45. United States Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Canada Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Mexico Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Europe Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 49. Europe Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 50. Europe Eye Injection Sales Quantity Market Share by Country (2019-2030)
Figure 51. Europe Eye Injection Consumption Value Market Share by Country (2019-2030)
Figure 52. Germany Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. France Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. United Kingdom Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Russia Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Italy Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Asia-Pacific Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 58. Asia-Pacific Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 59. Asia-Pacific Eye Injection Sales Quantity Market Share by Region (2019-2030)
Figure 60. Asia-Pacific Eye Injection Consumption Value Market Share by Region (2019-2030)
Figure 61. China Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Japan Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Korea Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. India Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Southeast Asia Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Australia Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. South America Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 68. South America Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 69. South America Eye Injection Sales Quantity Market Share by Country (2019-2030)
Figure 70. South America Eye Injection Consumption Value Market Share by Country (2019-2030)
Figure 71. Brazil Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Argentina Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Middle East & Africa Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 74. Middle East & Africa Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 75. Middle East & Africa Eye Injection Sales Quantity Market Share by Region (2019-2030)
Figure 76. Middle East & Africa Eye Injection Consumption Value Market Share by Region (2019-2030)
Figure 77. Turkey Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Egypt Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Saudi Arabia Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 80. South Africa Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 81. Eye Injection Market Drivers
Figure 82. Eye Injection Market Restraints
Figure 83. Eye Injection Market Trends
Figure 84. Porters Five Forces Analysis
Figure 85. Manufacturing Cost Structure Analysis of Eye Injection in 2023
Figure 86. Manufacturing Process Analysis of Eye Injection
Figure 87. Eye Injection Industrial Chain
Figure 88. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 89. Direct Channel Pros & Cons
Figure 90. Indirect Channel Pros & Cons
Figure 91. Methodology
Figure 92. Research Process and Data Source
Table 1. Global Eye Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Eye Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Eye Injection Product and Services
Table 6. Sanofi Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Eye Injection Product and Services
Table 11. Novartis Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Eye Injection Product and Services
Table 16. Bayer Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. Genentech Basic Information, Manufacturing Base and Competitors
Table 19. Genentech Major Business
Table 20. Genentech Eye Injection Product and Services
Table 21. Genentech Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Genentech Recent Developments/Updates
Table 23. Apellis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Apellis Pharmaceuticals, Inc. Major Business
Table 25. Apellis Pharmaceuticals, Inc. Eye Injection Product and Services
Table 26. Apellis Pharmaceuticals, Inc. Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 28. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Coherus BioSciences Inc. Major Business
Table 30. Coherus BioSciences Inc. Eye Injection Product and Services
Table 31. Coherus BioSciences Inc. Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Coherus BioSciences Inc. Recent Developments/Updates
Table 33. Iveric Bio
Basic Information, Manufacturing Base and Competitors
Table 34. Iveric Bio
Major Business
Table 35. Iveric Bio
Eye Injection Product and Services
Table 36. Iveric Bio
Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Iveric Bio
Recent Developments/Updates
Table 38. Regeneron Basic Information, Manufacturing Base and Competitors
Table 39. Regeneron Major Business
Table 40. Regeneron Eye Injection Product and Services
Table 41. Regeneron Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Regeneron Recent Developments/Updates
Table 43. Roche Basic Information, Manufacturing Base and Competitors
Table 44. Roche Major Business
Table 45. Roche Eye Injection Product and Services
Table 46. Roche Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Roche Recent Developments/Updates
Table 48. Fagron Basic Information, Manufacturing Base and Competitors
Table 49. Fagron Major Business
Table 50. Fagron Eye Injection Product and Services
Table 51. Fagron Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Fagron Recent Developments/Updates
Table 53. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 55. Qilu Pharmaceutical Co.,Ltd. Eye Injection Product and Services
Table 56. Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 58. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 59. Chengdu Kanghong Pharmaceutical Group Major Business
Table 60. Chengdu Kanghong Pharmaceutical Group Eye Injection Product and Services
Table 61. Chengdu Kanghong Pharmaceutical Group Eye Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 63. Global Eye Injection Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 64. Global Eye Injection Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Eye Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 66. Market Position of Manufacturers in Eye Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Eye Injection Production Site of Key Manufacturer
Table 68. Eye Injection Market: Company Product Type Footprint
Table 69. Eye Injection Market: Company Product Application Footprint
Table 70. Eye Injection New Market Entrants and Barriers to Market Entry
Table 71. Eye Injection Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Eye Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 73. Global Eye Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 74. Global Eye Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Eye Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Eye Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 77. Global Eye Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 78. Global Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 79. Global Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 80. Global Eye Injection Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Eye Injection Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Eye Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 83. Global Eye Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 84. Global Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 85. Global Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 86. Global Eye Injection Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Eye Injection Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Eye Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 89. Global Eye Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 90. North America Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 91. North America Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 92. North America Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 93. North America Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 94. North America Eye Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 95. North America Eye Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 96. North America Eye Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Eye Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 99. Europe Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 100. Europe Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 101. Europe Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 102. Europe Eye Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 103. Europe Eye Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 104. Europe Eye Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Eye Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 107. Asia-Pacific Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 108. Asia-Pacific Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 109. Asia-Pacific Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 110. Asia-Pacific Eye Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 111. Asia-Pacific Eye Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 112. Asia-Pacific Eye Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Eye Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 115. South America Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 116. South America Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 117. South America Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 118. South America Eye Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 119. South America Eye Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 120. South America Eye Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Eye Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Eye Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 123. Middle East & Africa Eye Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 124. Middle East & Africa Eye Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 125. Middle East & Africa Eye Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 126. Middle East & Africa Eye Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 127. Middle East & Africa Eye Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 128. Middle East & Africa Eye Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Eye Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Eye Injection Raw Material
Table 131. Key Manufacturers of Eye Injection Raw Materials
Table 132. Eye Injection Typical Distributors
Table 133. Eye Injection Typical Customers
LIST OF FIGURE
s
Figure 1. Eye Injection Picture
Figure 2. Global Eye Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Eye Injection Consumption Value Market Share by Type in 2023
Figure 4. Ranibizumab Examples
Figure 5. Bevacizumab Examples
Figure 6. Aflibercept Examples
Figure 7. Brolucizumab Examples
Figure 8. Faricimab Examples
Figure 9. Others Examples
Figure 10. Global Eye Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Eye Injection Consumption Value Market Share by Application in 2023
Figure 12. Age-related Macular Degeneration (AMD) Examples
Figure 13. Diabetic Retinopathy Examples
Figure 14. Retinal Vein Occlusion (RVO) Examples
Figure 15. Retinopathy of Prematurity (ROP) Examples
Figure 16. Uveitis Examples
Figure 17. Neovascular Glaucoma Examples
Figure 18. Others Examples
Figure 19. Global Eye Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 20. Global Eye Injection Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 21. Global Eye Injection Sales Quantity (2019-2030) & (K Units)
Figure 22. Global Eye Injection Average Price (2019-2030) & (US$/Unit)
Figure 23. Global Eye Injection Sales Quantity Market Share by Manufacturer in 2023
Figure 24. Global Eye Injection Consumption Value Market Share by Manufacturer in 2023
Figure 25. Producer Shipments of Eye Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 26. Top 3 Eye Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 27. Top 6 Eye Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 28. Global Eye Injection Sales Quantity Market Share by Region (2019-2030)
Figure 29. Global Eye Injection Consumption Value Market Share by Region (2019-2030)
Figure 30. North America Eye Injection Consumption Value (2019-2030) & (USD Million)
Figure 31. Europe Eye Injection Consumption Value (2019-2030) & (USD Million)
Figure 32. Asia-Pacific Eye Injection Consumption Value (2019-2030) & (USD Million)
Figure 33. South America Eye Injection Consumption Value (2019-2030) & (USD Million)
Figure 34. Middle East & Africa Eye Injection Consumption Value (2019-2030) & (USD Million)
Figure 35. Global Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 36. Global Eye Injection Consumption Value Market Share by Type (2019-2030)
Figure 37. Global Eye Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 38. Global Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 39. Global Eye Injection Consumption Value Market Share by Application (2019-2030)
Figure 40. Global Eye Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 41. North America Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 42. North America Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 43. North America Eye Injection Sales Quantity Market Share by Country (2019-2030)
Figure 44. North America Eye Injection Consumption Value Market Share by Country (2019-2030)
Figure 45. United States Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Canada Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Mexico Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Europe Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 49. Europe Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 50. Europe Eye Injection Sales Quantity Market Share by Country (2019-2030)
Figure 51. Europe Eye Injection Consumption Value Market Share by Country (2019-2030)
Figure 52. Germany Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. France Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. United Kingdom Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Russia Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Italy Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Asia-Pacific Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 58. Asia-Pacific Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 59. Asia-Pacific Eye Injection Sales Quantity Market Share by Region (2019-2030)
Figure 60. Asia-Pacific Eye Injection Consumption Value Market Share by Region (2019-2030)
Figure 61. China Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Japan Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Korea Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. India Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Southeast Asia Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Australia Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. South America Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 68. South America Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 69. South America Eye Injection Sales Quantity Market Share by Country (2019-2030)
Figure 70. South America Eye Injection Consumption Value Market Share by Country (2019-2030)
Figure 71. Brazil Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Argentina Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Middle East & Africa Eye Injection Sales Quantity Market Share by Type (2019-2030)
Figure 74. Middle East & Africa Eye Injection Sales Quantity Market Share by Application (2019-2030)
Figure 75. Middle East & Africa Eye Injection Sales Quantity Market Share by Region (2019-2030)
Figure 76. Middle East & Africa Eye Injection Consumption Value Market Share by Region (2019-2030)
Figure 77. Turkey Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Egypt Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Saudi Arabia Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 80. South Africa Eye Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 81. Eye Injection Market Drivers
Figure 82. Eye Injection Market Restraints
Figure 83. Eye Injection Market Trends
Figure 84. Porters Five Forces Analysis
Figure 85. Manufacturing Cost Structure Analysis of Eye Injection in 2023
Figure 86. Manufacturing Process Analysis of Eye Injection
Figure 87. Eye Injection Industrial Chain
Figure 88. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 89. Direct Channel Pros & Cons
Figure 90. Indirect Channel Pros & Cons
Figure 91. Methodology
Figure 92. Research Process and Data Source
